JUUL Labs is pleased to announce our purchase of the 123 Mission Street building in San Francisco, which will serve as additional office space to accommodate our rapidly growing team. We have always been a proud San Francisco-based company, and remain committed to serving the community as we focus on helping adult smokers switch from combustible cigarettes — the leading cause of preventable death — and combating underage use.
February 18, 2021
An emerging public health issue, illicit vapor products undermine underage-prevention measures and may present additional health and safety risks for adult consumers.
February 11, 2021
As we continue to do our part to support enforcement against black-market vapor products in the United States and abroad, Juul Labs is pleased to announce the disruption of another illicit enterprise involved in the manufacture and international distribution of counterfeit JUUL products in China.
November 6, 2020
Juul Labs Chief Regulatory Officer Joe Murillo recently participated in a panel discussion at the 2020 Food & Drug Law Institute (FDLI) Tobacco and Nicotine Products Regulation and Policy Conference, where he discussed the role of nicotine in tobacco harm reduction.